PLOD1 and polycystic ovary syndrome: Increases in oxidative stress levels and inflammatory markers, LH and androgens, and a significant reduction in follicle stimulating hormone (FSH) and estrogen have been reported in patients with PCOS and also in animal models of PCOS (7, 8).